1. Akahira-Azuma M, Tsurusaki Y, Enomoto Y, Mitsui J, Kurosawa K. Refining the clinical phenotype of Okur-Chung neurodevelopmental syndrome. Hum Genome Var. 2018;5:18011–3.
2. Bandyopadhyay M, Bishop CP, Bidwai AP. The conserved MAPK site in E(spl)-M8, an effector of Drosophila Notch signaling, controls repressor activity during eye development. PLoS One. 2016;11(7):e0159508.
3. Chiu ATG, Pei SLC, Mak CCY, Leung GKC, Yu MHC, Lee SL, et al. Okur-Chung neurodevelopmental syndrome: eight additional cases with implications on phenotype and genotype expansion. Clin Genet. 2018;93(4):880–90.
4. Colavito D, Del Giudice E, Ceccato C, Dalle Carbonare M, Leon A, Suppiej A. Are CSNK2A1 gene mutations associated with retinal dystrophy? Report of a patient carrier of a novel de novo splice site mutation. J Hum Genet. 2018;63(6):779–81.
5. Freeman-Anderson NE, Zheng Y, McCalla-Martin AC, Treanor LM, Zhao YD, Garfin PM, et al. Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development. Development. 2009;136(12):2081–9.